Consumer goods arm of GSK hits stock market | This is Money
Glaxo's (GSK) Q1 Earnings Top, Xevudy Adds $1.7B in Sales | Nasdaq
4 Reasons Why You Should Add Glaxo (GSK) to Your Portfolio
Glaxosmithkline Pharmaceuticals Share Price today, Market Cap, Shareholding, Financials
Better Buy: GlaxoSmithKline vs. Eli Lilly | The Motley Fool
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
Glaxo (GSK) Q4 Earnings Top Estimates, Xevudy Adds $1.1B in Sales | Nasdaq
GSK Stock Price and Chart — LSE:GSK — TradingView
Haleon or GSK – which is the better play?
Glaxo (GSK) to Report Q4 Earnings: What's in the Cards?
Unilever Needs $10 Billion Bump to Win Glaxo Unit, Analysts Say - BNN Bloomberg
GlaxoSmithKline: Back To The Drawing Board (NYSE:GSK) | Seeking Alpha
Better Buy: Eli Lilly vs. GlaxoSmithKline | The Motley Fool
UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg
Taking A Look At The Special Situation With GlaxoSmithKline (NYSE:GSK) | Seeking Alpha
London stock market listing of up to £45bn looms as GSK investors vote for demerger | GlaxoSmithKline | The Guardian
Elliott Publishes Letter on GlaxoSmithKline
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022
GSK (GSK) Stock Price, News & Info | The Motley Fool
Why are GlaxoSmithKline (GSK) shares so low? (LON:GSK) - Good Money Guide
GlaxoSmithKline demerger: GSK spin-off Haleon date and details in full
UK Drugmaker GSK Needs to Show It's Kicked the Dealmaking Addiction - Bloomberg
Glaxo Underperforms Industry in a Year: What's in Store?
